SCHEMBL6739607

SCHEMBL6739607

CCCCCCCCOc1ccc(S(=O)(=O)C(=[N+]=[N-])S(=O)(=O)C2CCCCC2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.44
MAPK1 P28482 1/20 0.44
RECQL P46063 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
NR5A1 Q13285 1/20 0.41
TP53 P04637 1/20 0.40
PLA2G4B P0C869 1/20 0.40
LMNA P02545 2/20 0.39
THRA P10827 1/20 0.39
THRB P10828 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
LTA4H P09960 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6736211 1.00 TSHR (0.44) TSHRMAPK1RECQLL3MBTL1CA12
SCHEMBL5881654 0.91 THRA (0.39) TSHRMAPK1RECQLL3MBTL1CA12
SCHEMBL6736840 0.88 TSHR (0.50) TSHRMAPK1RECQLL3MBTL1CA12
SCHEMBL6735762 0.88 TSHR (0.50) TSHRMAPK1RECQLL3MBTL1CA12
SCHEMBL5881892 0.87 TSHR (0.40) TSHRMAPK1RECQLL3MBTL1CA12
SCHEMBL383894 0.86 TSHR (0.53) TSHRMAPK1RECQLL3MBTL1CA12
SCHEMBL6743900 0.86 TSHR (0.53) TSHRMAPK1RECQLL3MBTL1CA12
SCHEMBL6741875 0.86 TSHR (0.53) TSHRMAPK1RECQLL3MBTL1CA12
SCHEMBL6742374 0.86 TSHR (0.53) TSHRMAPK1RECQLL3MBTL1CA12
SCHEMBL6743983 0.86 TSHR (0.53) TSHRMAPK1RECQLL3MBTL1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689530-B2 ULTRAVIOLET LITHOGRAPHY MICROFABRICATION WITH IMPROVED RESOLUTION AND PATTERN PROFILE AFTER DEVELOPMENT SHIN-ETSU CHEMICAL CO., LTD. (JP) 2004-02-10 US disclosed
US-20030180653-A1 Novel sulfonyldiazomethanes, photoacid generations, resist compositions, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2003-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030180653-A1 Novel sulfonyldiazomethanes, photoacid generations, resist compositions, and patterning process CACNA1A, KCNA1, POLL TSHR 3831/4885MAPK1 1708/4885RECQL 342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.